The year's new drugs.
The United States was the most active market for new product launches (22 products, 62.5%) in a year that saw 35 new chemical entities and biological drugs and two diagnostic agents reach their first markets. The most active therapeutic groups were anti-infective, oncolytic and metabolic drugs with five launches for each.
Graul
Ann I
AI
D000700:Analgesics / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001688:Biological Products; D002317:Cardiovascular Agents / Q000627:therapeutic use; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D004364:Pharmaceutical Preparations
D000700:Analgesics; D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D001688:Biological Products; D002317:Cardiovascular Agents; D005765:Gastrointestinal Agents; D004364:Pharmaceutical Preparations